Garrido; Antonio Romero

Patent Applications and Registrations

Patent applications and USPTO patent grants for Garrido; Antonio Romero.The latest application filed is for "use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ".

Company Profile

0.4.7

Garrido; Antonio Romero - Madrid ES
Garrido; Antonio Romero - Collado Villalba ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ Grant 9,248,114 - Sanchez , et al. February 2, 2	2016-02-02
Use Of 2,5-dihydroxybenzene Compounds And Derivatives For The Treatment Of Hematological Dyscrasias And Cancer Of An Organ App 20140206654 - Sanchez; Pedro Cuevas ; et al.	2014-07-24
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ Grant 8,541,467 - Sanchez , et al. September 24, 2	2013-09-24
Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer App 20120087904 - Sanchez; Pedro Cuevas ; et al.	2012-04-12
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer Grant 8,101,660 - Sanchez , et al. January 24, 2	2012-01-24
Use Of 2,5-dihydroxybenzene For The Treatment Of Ocular Diseases App 20120015912 - Sanchez; Pedro Cuevas ; et al.	2012-01-19
Use Of 2,5-dihydroxybenzene Compounds And Derivatives For The Treatment Of Psoriasis App 20110311528 - Sanchez; Pedro Cuevas ; et al.	2011-12-22
Use Of 2,5-dihydroxybenzene Derivatives For Treating Actinic Keratosis App 20110257264 - S?nchez; Pedro Cuevas ; et al.	2011-10-20
Use Of 2,5-dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea App 20110237555 - Sanchez; Pedro Cuevas ; et al.	2011-09-29
Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Hematological Dyscrasias and Cancer of an Organ App 20080125486 - Sanchez; Pedro Cuevas ; et al.	2008-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.